Marshall B. Elam
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 16
- Diabetes Treatment and Management 8
- Surgery top 0.5%
- Lipoproteins and Cardiovascular Health 24
- Cholesterol and Lipid Metabolism 20
- Biochemistry top 0.5%
- Lipid metabolism and biosynthesis 12
- Cancer Research top 2%
-
- Peroxisome Proliferator-Activated Receptors 12
-
- Adipose Tissue and Metabolism 10
-
- Liver Disease Diagnosis and Treatment 8
- Co-authors
- Hanna E. BloomfieldSander J. RobinsEdwards A. ParkJames W. AndersonDorothea CollinsFred H. FaasErnst J. SchaeferGordon Schectman
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)JAMA (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Marshall B. Elam
81 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Endocrinology, Diabetes and Metabolism 3.3k
- Surgery 3.7k
- Biochemistry 519
- Cancer Research 1.1k
- Cardiology and Cardiovascular Medicine 1.6k
Countries citing papers authored by Marshall B. Elam
This map shows the geographic impact of Marshall B. Elam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall B. Elam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall B. Elam more than expected).
Fields of papers citing papers by Marshall B. Elam
This network shows the impact of papers produced by Marshall B. Elam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall B. Elam. The network helps show where Marshall B. Elam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marshall B. Elam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 132 | |
| 2 | 2017 | 31 | |
| 3 | 2017 | 7 | |
| 4 | 2015 | 9 | |
| 5 | 2014 | 20 | |
| 6 | 2012 | 111 | |
| 7 | 2012 | 67 | |
| 8 | Abstract 19724: Hypertriglyceridemia and Low HDL-C Predicts Fenofibrate Response in The ACCORD-Lipid Trial | 2010 | 2 |
| 9 | 2009 | 60 | |
| 10 | 2008 | 254 | |
| 11 | 2007 | 73 | |
| 12 | 2007 | 45 | |
| 13 | 2007 | 4 | |
| 14 | 2005 | 40 | |
| 15 | 2001 | 60 | |
| 16 | 1998 | 20 | |
| 17 | 1995 | 190 | |
| 18 | 1993 | 81 | |
| 19 | 1988 | 41 | |
| 20 | 1987 | 7 |
About Marshall B. Elam
Marshall B. Elam is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Surgery, having authored 82 papers that have together received 7.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (24 papers), Cholesterol and Lipid Metabolism (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Peroxisome Proliferator-Activated Receptors (12 papers), Lipid metabolism and biosynthesis (12 papers), Adipose Tissue and Metabolism (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Diabetes Treatment and Management (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.3k citations), Surgery (3.7k citations) and Biochemistry (519 citations). Marshall B. Elam has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Hanna E. Bloomfield, Sander J. Robins, Edwards A. Park, James W. Anderson, Dorothea Collins, Fred H. Faas, Ernst J. Schaefer, Gordon Schectman, Timothy J Wilt and Carol L. Fye. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.